YCM
TVRD

Yousif Capital Management’s Tvardi Therapeutics TVRD Stock Holding History

Yousif Capital Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-723
Closed -$128K – 1997
2023
Q1 		$128K Sell
723
-75
-9% -$25.1K ﹤0.01% 1880
2022
Q4 		$309K Sell
798
-400
-33% -$152K ﹤0.01% 1700
2022
Q3 		$404K Buy
1,198
+18
+2% +$6.52K 0.01% 1609
2022
Q2 		$388K Sell
1,180
-80
-6% -$28.1K 0.01% 1644
2022
Q1 		$551K Sell
1,260
-30
-2% -$12.3K 0.01% 1600
2021
Q4 		$566K Buy
+1,290
New +$648K 0.01% 1616

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Yousif Capital Management's TVRD Position: Q2 2023 in Review

Yousif Capital Management sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 723 shares — an estimated $128K sold.

Yousif Capital Management first reported a position in TVRD in Q4 2021 and held it in 6 quarters. The position peaked at $566K in Q4 2021. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

  • Yousif Capital Management reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Yousif Capital Management sold 723 Tvardi Therapeutics shares in Q2 2023, an estimated $128K.
  • Yousif Capital Management first reported a position in Tvardi Therapeutics in Q4 2021 and held it in 6 quarters.
  • Yousif Capital Management's Tvardi Therapeutics position peaked at $566K in Q4 2021.
  • 137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Yousif Capital Management's 13F filing for Q2 2023, filed 2 Aug 2023.